Puri Pankaj, Anand Anil C, Saraswat Vivek A, Acharya Subrat K, Dhiman Radha K, Aggarwal Rakesh, Singh Shivram P, Amarapurkar Deepak, Arora Anil, Chhabra Mohinish, Chetri Kamal, Choudhuri Gourdas, Dixit Vinod K, Duseja Ajay, Jain Ajay K, Kapoorz Dharmesh, Kar Premashis, Koshy Abraham, Kumar Ashish, Madan Kaushal, Misra Sri P, Prasad Mohan V G, Nagral Aabha, Puri Amarendra S, Jeyamani R, Saigal Sanjiv, Sarin Shiv K, Shah Samir, Sharma P K, Sood Ajit, Thareja Sandeep, Wadhawan Manav
Department of Gastroenterology, Army Hospital (R & R), New Delhi 110010, India.
Department of Gastroenterology and Hepatology, Indraprastha Apollo Hospital, New Delhi 110076, India.
J Clin Exp Hepatol. 2014 Jun;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. Epub 2014 Jun 9.
Globally, around 150 million people are infected with hepatitis C virus (HCV). India contributes a large proportion of this HCV burden. The prevalence of HCV infection in India is estimated at between 0.5% and 1.5%. It is higher in the northeastern part, tribal populations and Punjab, areas which may represent HCV hotspots, and is lower in western and eastern parts of the country. The predominant modes of HCV transmission in India are blood transfusion and unsafe therapeutic injections. There is a need for large field studies to better understand HCV epidemiology and identify high-prevalence areas, and to identify and spread awareness about the modes of transmission of this infection in an attempt to prevent disease transmission.
全球范围内，约有1.5亿人感染丙型肝炎病毒（HCV）。印度在这一丙型肝炎病毒负担中占很大比例。据估计，印度丙型肝炎病毒感染率在0.5%至1.5%之间。在东北部、部落人口地区和旁遮普邦，感染率较高，这些地区可能是丙型肝炎病毒热点地区，而在该国西部和东部地区感染率较低。印度丙型肝炎病毒的主要传播方式是输血和不安全的治疗性注射。需要开展大规模的实地研究，以更好地了解丙型肝炎病毒流行病学，确定高流行地区，并识别和传播有关这种感染传播方式的认识，以预防疾病传播。
